ID: ALA366877

Max Phase: Preclinical

Molecular Formula: C11H9F3N2S

Molecular Weight: 258.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1sc(N)nc1-c1ccc(C(F)(F)F)cc1

Standard InChI:  InChI=1S/C11H9F3N2S/c1-6-9(16-10(15)17-6)7-2-4-8(5-3-7)11(12,13)14/h2-5H,1H3,(H2,15,16)

Standard InChI Key:  SUDKFQSYTBBEGL-UHFFFAOYSA-N

Associated Targets(non-human)

Apical membrane antigen 1 72 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 258.27Molecular Weight (Monoisotopic): 258.0439AlogP: 3.72#Rotatable Bonds: 1
Polar Surface Area: 38.91Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.62CX LogP: 4.04CX LogD: 4.04
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.85Np Likeness Score: -1.66

References

1. Yamaguchi K, Yada M, Tsuji T, Hatanaka Y, Goda K, Kobori T..  (1999)  4-Phenylthiazole derivatives inhibit IL-6 secretion in osteoblastic cells and suppress bone weight loss in ovariectomized mice.,  (7): [PMID:10230619] [10.1016/s0960-894x(99)00122-5]
2. Devine SM, Mulcair MD, Debono CO, Leung EW, Nissink JW, Lim SS, Chandrashekaran IR, Vazirani M, Mohanty B, Simpson JS, Baell JB, Scammells PJ, Norton RS, Scanlon MJ..  (2015)  Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffold.,  58  (3): [PMID:25559643] [10.1021/jm501402x]

Source